The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; none of the 83 sources its claims cite is checked for support yet.
Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1β Production
Open accessAbstract
Objective—: The calcium composition of atherosclerotic plaque is thought to be associated with increased risk for cardiovascular events, but whether plaque calcium itself is predictive of worsening clinical outcomes remains highly controversial. Inflammation is likely a key mediator of vascular calcification, but immune signaling mechanisms that promote this process are minimally understood. Approach and Results—: Here, we identify Rac2 as a major inflammatory regulator of signaling that directs plaque osteogenesis. In experimental atherogenesis, Rac2 prevented progressive calcification through its suppression of Rac1-dependent macrophage interleukin-1β (IL-1β) expression, which in turn is a key driver of vascular smooth muscle cell calcium deposition by its ability to promote osteogenic transcriptional programs. Calcified coronary arteries from patients revealed decreased Rac2 expression but increased IL-1β expression, and high coronary calcium burden in patients with coronary artery disease was associated with significantly increased serum IL-1β levels. Moreover, we found that elevated IL-1β was an independent predictor of cardiovascular death in those subjects with high coronary calcium burden. Conclusions—: Overall, these studies identify a novel Rac2-mediated regulation of macrophage IL-1β expression, which has the potential to serve as a powerful biomarker and therapeutic target for atherosclerosis.
Overview
CoChat Summary
Written by AI from the paper’s full text.
TL;DR
Rac2 suppresses macrophage IL-1β production by limiting Rac1 activity, and loss of Rac2 promotes atherosclerotic calcification in mice. In humans, calcified coronary plaque has lower Rac2 and higher IL-1β, and elevated serum IL-1β predicts cardiovascular death in patients with high coronary calcium burden.
Key findings
- In ApoE−/− mice on high-fat diet, aortic calcification rose modestly to 14 weeks then dramatically between 14 and 21 weeks; Rac2 expression initially tracked macrophage influx but fell at 21 weeks despite sustained F4/80, while IL-1β increased significantly between 14 and 21 weeks.
- Human calcified coronary segments had significantly reduced Rac2 mRNA and increased IL-1β expression, with unchanged Rac1 and CSF1R; Rac2−/−ApoE−/− mice showed increased macrocalcification, osteogenic genes RUNX2/SOX9/OSX/MSX2, and ALP.
- Bone marrow transplantation showed the calcification phenotype tracked with hematopoietic Rac2: Rac2−/− marrow into Rac2+/+ recipients increased calcification, while Rac2+/+ marrow into Rac2−/− recipients decreased it; serum IL-1β was elevated in mice receiving Rac2−/− marrow.
- In human stable CAD, serum IL-1β correlated with CACS; high calcium burden had HR 4.88 (95% CI 1.03–22.98, P=0.045) for cardiovascular events (10 total: 6 sudden cardiac deaths, 1 STEMI, 2 NSTEMI, 1 ACS), and all events occurred in subjects with IL-1β >1.8 pg/ml.
Methods
- Mouse studies used ApoE−/− and Rac2−/−ApoE−/− mice on high-fat diet, with near-infrared bisphosphonate imaging, microCT, histology, RNA/protein analyses, bone marrow transplantation, BMDMs, MASMCs, and IL-1ra treatment.
- Human studies analyzed coronary segments from explanted hearts of patients undergoing orthotopic heart transplant for ischemic cardiomyopathy, classified as calcified vs noncalcified by noncontrast CT Agatston criteria and EVG staining; a separate chronic stable CAD cohort had serum IL-1β measured and coronary artery calcium scoring by non-ECG-gated non-contrast chest CT.
- Main analyses compared expression/calcification between groups, tested IL-1β signaling dependence with inhibitors/genetic deletion, and assessed clinical associations/outcomes including hazard ratio.
Limitations
- The paper states the human clinical analysis requires further study because the sample size is small and the analysis is retrospective.
- Evident from the text: mechanistic cause-effect conclusions rely heavily on mouse models and cell culture, while human data are associative; the human coronary expression analysis uses explanted hearts from transplant patients, which may not represent broader CAD populations.
- Methods details are in the online-only Data Supplement, so the main text alone does not allow full assessment of experimental procedures.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
70 Own result · 27 Not checked yet · 19 Own interpretation · 4 Own method · 1 Sources not found
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of note, IL-1β expression was found to be significantly increased in the coronary artery segments containing calcified plaque in a manner consistent with the animal model (Fig. 1J).”
§ Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage IL-1β Production > Results > Calcified plaque is associated with increased IL-1β and decreased Rac2 expression
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Rac2−/−ApoE−/− aortas contained additional areas of hyperattenuation indicative of macrocalcification along the lesser curvature of the aortic arch (Fig. 2A, upper panels, yellow arrows), which was further confirmed by quantification of Alizarin Red staining (Fig. 2A, lower panels, and 2B).”
§ Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage IL-1β Production > Results > Rac2 deletion leads to increased plaque calcification
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hematoxylin and eosin staining of aortic sinus plaque and quantification of plaque area revealed similar plaque burden in Rac2+/+ApoE−/− and Rac2−/−ApoE−/− mice (Fig. ID,E).”
§ Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage IL-1β Production > Results > Rac2 deletion does not affect serum cholesterol or plaque lipid composition
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“elevated IL-1β was an independent predictor of cardiovascular death in those subjects with high coronary calcium burden.”
§ Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage IL-1β Production > Abstract > Approach and Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In experimental atherogenesis, Rac2 prevented progressive calcification through its suppression of Rac1-dependent macrophage IL-1β expression”
- Also stated in: § Rac2 deletion leads to increased plaque calcification · plain
“Rac2−/−ApoE−/− aortas from mice on HFD for 14 weeks revealed significant increases in relative calcification over mice fed normal chow or control mice on a HFD.”
§ Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage IL-1β Production > Abstract > Approach and Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Rac2 deletion leads to increased plaque calcification · plain
- It may state two separate claims as one. 24
- Probably not a substantial claim. 23
Create a free account to see these claims.
Create a free account to see these assumptions.
71 more claims
Create a free account to see all 121 claims and to verify the 82 references still open.
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Quantification of coronary artery calcium using ultrafast computed tomography
Agatston, A. S., Janowitz, W. R., Hildner, F. J., Zusmer, N. R., Viamonte, M., & Detrano, R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90282-t · Cited by 7,786
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437741.48606.98 · Cited by 3,697
From Vulnerable Plaque to Vulnerable Patient
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S. H., Rumberger, J. A., Badimón, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087481.55887.c9 · Cited by 2,679
From Vulnerable Plaque to Vulnerable Patient
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S. H., Rumberger, J. A., Badimón, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087480.94275.97 · Cited by 2,298
Mammalian Rho GTPases: new insights into their functions from in vivo studies
Heasman, S. J., & Ridley, A. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2476 · Cited by 1,871
Motoyama, S., Sarai, M., Harigaya, H., Anno, H., Inoue, K., Hara, T., Naruse, H., Ishii, J., Hishida, H., Wong, N. D., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.068 · Cited by 1,436
Cited by
Items 101–124 of 124
Endothelial TRIM35‐Regulated MMP10 Release Exacerbates Calcification of Vascular Grafts
Leng, Y., Wang, W., Lü, J., Chen, J., Chen, X., Li, Y., Wang, J., Liu, Y., Tan, Q., Yang, W., et al. (2025) · Advanced Science · doi:10.1002/advs.202409641 · Cited by 3
The Role and Mechanism of Gut Microbiota and Metabolites in Vascular Calcification
Cao, X., Zhang, A.-Y., Li, K.-F., Bie, Y.-W., Xu, G.-W., Zhou, C.-Y., Ma, X., Zhuang, Y., Sun, H.-J., & Zhu, X.-X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031364 · Cited by 3
Age-Associated Calcification: Insights from Murine Models
Nasi, S., Romani, M., & Busso, N. (2024) · Gout Urate and Crystal Deposition Disease · doi:10.3390/gucdd2030018 · Cited by 3
Li, H., Li, R., Gong, C., Wu, Z., & Jia, Q. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1415151 · Cited by 2
Shams, S. S., Ghoneim, M. T., Ghareeb, D. A., Masoud, A. A., & Zakaria, H. S. (2025) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001748 · Cited by 1
Kong, D. Z., Zhang, X. Z., Zhou, Y., Wang, Q., Pan, Y. H., Lu, Y., Ye, H., & Hong, X. Y. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05533-1 · Cited by 1
Would acetazolamide inhibit progression of atheromatous vascular calcification?
Cochran, M. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109354 · Cited by 1
Liu, Q., Chan, K. H. K., Morrison, A., McGarvey, S. T., Luo, X., Wilson, J. G., Correa, A., Reiner, A. P., Li, J., Liu, S., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/726208 · Cited by 1
Self-citationVastrad, B. M., & Vastrad, C. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.08.495272 · Cited by 1
Kurt, Z., Cheng, J. Y., McQuillen, C. N., Saleem, Z., Hsu, N., Jiang, N., Barrere‐Cain, R., Pan, C., Franzén, O., Koplev, S., et al. (2023) · eLife · doi:10.7554/elife.88266.1
Kurt, Z., Cheng, J. Y., Barrere‐Cain, R., McQuillen, C. N., Saleem, Z., Hsu, N., Jiang, N., Pan, C., Franzén, O., Koplev, S., et al. (2023) · eLife · doi:10.7554/elife.88266.3.sa3
Cai, Z., She, J., Guo, S., Li, R., Zhang, H., Guo, X., & Wu, S. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04219-w
Lee, S., Guo, Y. Y., Kajuluri, L. P., Roh, K., Singh, K., Jiang, W., Moore, E., Tattersfield, H., Ostrom, K. F., Birchenough, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.08.663801
Additional file 2 of Myeloid CCN3 protects against aortic valve calcification
Tu, P., Xu, Q., Zhou, X., Villa-Roel, N., Kumar, S., Dong, N., Jo, H., Ou, C., & Lin, Z. (2023) · Figshare · doi:10.6084/m9.figshare.22610938
Jia, J., Zhang, J., He, Q., Wang, M., Liu, Q., Wang, T., Chen, X., Wang, W., & Xu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26640268
Lee, G.-L., Liao, T.-L., Wu, J.-Y., Wu, K. K., & Kuo, C.-C. (2021) · Figshare · doi:10.6084/m9.figshare.16960268
Kawtharany, L. (2022) · theses.fr (ABES) · doi:10.70675/8266a539zd176z4839zb688z6235f93ffe7c
Tseng, Y.-S., Tseng, H., Ku, P.-W., Lai, H.-P., Chang, T.-H., Chuang, W., & Wu, J. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1831072
The Role of Macrophages in Atherosclerosis Development
Bezsonov, E. E., Gavrilova, D., Grebenshchikov, E. S., Grinev, A., Puchinova, E., Kuzmin, V., Oganesyan, A., Bogomolov, D., Degtyarevskaya, T., Lazareva, Y. B., et al. (2026) · Gene Expression · doi:10.14218/ge.2025.00080
Diabetic plaque calcification: mechanisms, imaging phenotypes, and clinical implications
Zhu, M., Wang, W., Xu, S., Li, Y., Liu, Y., & Liu, Y. (2026) · npj Metabolic Health and Disease · doi:10.1038/s44324-026-00129-x
The Big Five Functional Levels of Vascular Calcification
Villa‐Bellosta, R. (2026) · Biology · doi:10.3390/biology15191708
Research Progress on Mechanisms and Pharmacological Interventions of Coronary Artery Calcification
Wang, Y., & Duan, N. (2026) · Angiology · doi:10.1177/00033197261492091
Chen, Q., Guo, S., Li, X., Li, Y., Xie, Y., Fu, S., Ma, R., Peng, X., Xie, S., Gao, Y., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1974775
Xu, J., Chen, L., Liu, Y., Mushajiang, M., Xie, L., & Wang, Z. (2026) · Biomolecules · doi:10.3390/biom16111631
Metadata
- Authors
- Ceneri, N., Zhao, L., Young, B. D., Healy, A., Coskun, S., Vasavada, H., Yarovinsky, T. O., Ike, K., Pardi, R., Qin, L., Qin, L., Tellides, G., Hirschi, K., Meadows, J., Soufer, R., Chun, H. J., Sadeghi, M. M., Bender, J. R., & Morrison, A. R.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- From the Department of Internal Medicine (Section of Cardiovascular Medicine), VA Connecticut Healthcare System, West Haven (N.C., L.Z., A.H., L.Q., G.T., J.M., R.S., M.M.S., A.R.M.); Department of Medicine and Division of Cardiology, Providence VA Medical Center, RI (A.H., A.R.M.); Department of Internal Medicine (Section of Cardiovascular Medicine), Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT (N.C., L.Z., B.D.Y., A.H., S.C., H.V., T.O.Y., K.I., L.Q., L.Q....
- Corresponding author
- Ceneri, Nicolle
- Zhao, Lina
- ORCID
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2017-02
- Volume
- 37
- Issue
- 2
- Pages
- 328-340
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- PMC
- PMC5269510
- OpenAlex
- W2551261660
- Cited by
- 124
- References
- 54
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 15 · 2023: 18 · 2022: 16 · 2021: 14 · 2020: 17 · 2019: 14 · 2018: 8 · 2017: 4
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs (IK2BX002527)
- Swedish Orphan Biovitrum
- National Institutes of Health (UL1TR001863)
- National Heart, Lung, and Blood Institute (R01HL043331, R01HL113005, L30 HL115713, F32HL097422, R01HL128064, T32HL007950)
- National Cancer Institute (P30CA016359)
- National Institute of General Medical Sciences (P20GM103652)
- National Institute of Biomedical Imaging and Bioengineering (R01EB016629, UH3EB017103)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Rac2, atherosclerotic calcification, vascular calcification, IL-1β, macrophages, Rac1, vascular smooth muscle cells, coronary artery disease, cardiovascular mortality, inflammation, biomarkers, therapeutic target
- MeSH terms
- RAC2 GTP-Binding Protein, Animals, Aorta, Aortic Diseases, Apolipoproteins E, Cells, Cultured, Coronary Artery Disease, Coronary Vessels, Female, Humans, Macrophages, Male, Mice, Inbred C57BL, Muscle, Smooth, Vascular, Neuropeptides, Phenotype, Prognosis, Transfection, Signal Transduction, Up-Regulation, Mice, Knockout, Inflammation Mediators, Genetic Predisposition to Disease, rac GTP-Binding Proteins, rac1 GTP-Binding Protein, Myocytes, Smooth Muscle, Atherosclerosis, Interleukin-1beta, Interleukin 1 Receptor Antagonist Protein, Plaque, Atherosclerotic, Vascular Calcification
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
